EVALUATION OF INTENSITY OF HUMORAL IMMUNITY TO MEASLES AND RUBELLA IN PREGNANT WOMEN IN MOSCOW

Cover Page


Cite item

Full Text

Abstract

Aim. Qualitative and quantitative evaluation of humoral immunity regarding causative agents of controllable infections in pregnant women in Moscow. Materials and methods. Sera of 559 pregnant and 201 non-pregnant women were studied for the presence of antibodies against measles and rubella virus by ELISA. Results. A significant proportion of individuals seronegative to measles was detected among pregnant (21.5%) and non-pregnant (29.1%) women aged 18 - 45, that exceeds the level acceptable by regulatory requirements by 3.1 and 4.2 times, respectively. The parameter increased with age and among seropositive individuals a high concentration of IgG against measles was noted. This gives evidence, that older individuals are not covered by measles vaccination enough, and a significant part of them has post-infection immunity that is higher and more robust compared with post-vaccination. Regarding rubella infection, a more favorable situation was established: proportion of seronegative individuals among the examined was 8.9 and 10.5%, respectively. The proportion of seronegative individuals decreased with age, and by age 36 - 45 reached the minimal 4,7%. A maximum amount of rubella seronegative individuals was detected in the 26-30 age group - 12.5%, as well as maximum proportion of individuals who have high concentration of specific IgG. An increase of the amount of seronegative results was observed with the increase of gestation period for both infections. Correlation between intensity of immunity against measles and rubella in the examined women was not present. Conclusion. Means for development of extra vaccination of the adult population and execution of laboratory examination of pregnant and women planning pregnancy are proposed regarding not only rubella, but also measles.

About the authors

A. V. Nozdracheva

Gamaleya Federal Research Centre of Epidemiology and Microbiology

Author for correspondence.
Email: noemail@neicon.ru
Russian Federation

T. A. Semenenko

Gamaleya Federal Research Centre of Epidemiology and Microbiology

Email: noemail@neicon.ru
Russian Federation

S. G. Mardanly

State Humanitarian-Technological University

Email: noemail@neicon.ru
Russian Federation

S. V. Rotanov

Russian Medical Academy of Post-Graduate Education

Email: noemail@neicon.ru
Russian Federation

References

  1. Голева О.В., Самойлова И.Г., Мурина Е.А., Мундруева А.А. Особенности противокоревого иммунитета. Эпидемиология и вакцинопрофилактика. 2012, 6:25-29.
  2. Инфекционная заболеваемость в Российской Федерации за январь-май 2016 г. (по данным формы № 1 «Сведения об инфекционных и паразитарных заболеваниях»), http:// rospotrebnadzor.ru/activities/statistical_materials/statictic_details.php? ELEMENT_ ID=6643, опубликовано 17.06.2016.
  3. Информационный бюллетень ВОЗ № 366 Ноябрь 2015 г. http://www.who.int.
  4. Корь. Информационный бюллетень № 286. Февраль 2015 г. http://www.who.int.
  5. Лыткина И.Н. Создание унифицированной системы управления эпидемическим процессом кори, краснухи и эпидемического паротита. Автореф. дис. д-ра мед. наук. М., 2011.
  6. Онищенко ГГ., Ежлова Е.Б., Лазикова Г.Ф., Мельникова А. А., Ватолина А. А., Тихонова Н.Т., Герасимова А. Г. Реализация программы ликвидации кори в Российской Федерации. Журн. микробиол. 2011, 4: 51-56.
  7. Организация и проведение серологического мониторинга состояния коллективного иммунитета к инфекциям, управляемым средствами специфической профилактики (дифтерия, столбняк, коклюш, корь, краснуха, эпидемический паротит, полиомиелит, гепатит В). Методические указания. МУ 3.1.2943-11. http://36.rospotrebnadzor.ru/ documents/rekdoc 1/9396.
  8. Профилактика кори, краснухи, эпидемического паротита. Санитарные правила. СП 3.1 -2952-11. http://snipov.net/database/c_4163967195_doc_4293851299.html.
  9. Семененко Т.А., Ежлова Е.Б., Ноздрачева А.В., Русакова Е.В. Особенности проявления эпидемического процесса кори в 1992-2014 годах в Москве. Эпидемиология и вакцинопрофилактика. 2015, 6 (85): 16-23.
  10. Топтыгина А.П. Комплексная оценка процессов формирования и поддержания иммунологической памяти на примере вакцинации против кори, краснухи и эпидемического паротита: Автореф. дисс. д-ра мед. наук. М., 2015.
  11. Шмитько А.Д, Костинов М.П., Бочарова И.И., Сависько А.А., Магаршак О.О., Полищук В.Б. Трансплацентарные lgG к вирусу кори в пуповинной крови у новорожденных разных регионов Российской Федерации. Журн. микробиол. 2015, 1: 52-57.
  12. Behnam Honarvar, Mohsen Moghadami, Afagh Moattari et al. Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: Outcomes of a nationwide measles-rubella mass vaccination. http://www.ncbi.nlm.nih.gov/pubmed/PMCID: PMC3561451.
  13. Colleen M. Kennedy, Barbara A. Burns, Kevin A. Ault. Does rubella immunity predict measles immunity? A serosurvey of pregnant, http://www.ncbi.nlm.nih.gov/pubmed/ doi: 10.1155/ IDOG/2006/13890.
  14. Castillo-SolorzanoC., ReefS. E., Morice A. etal. Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001-2008. J. Infect. Dis. 2011 (Sep); 1; 204 Suppl. 2: S713-7. http://www.ncbi.nim. nih.gov/pubmed/ doi: 10.1093/infdis/jir489.
  15. Kanda E., Yamaguchi K., Hanaoka M. et al. Low titers of measles antibodies in Japanese pregnant women: a single-center study J. Obstet. Gynaecol. Res. 2013 (Feb); 39 (2): 500-503. http://www.ncbi.nlm.nih.gov/pubmed/doi: 10.1111/j. 1447-0756.2012.01997.x.
  16. Miller E.M. Changes in serum immunity during pregnancy. Am. J. Hum. Biol. 2009 (May-Jun); 21 (3): 401-403. http://www.ncbi.nlm.nih.gov/pubmed/doi: 10.1002/ajhb.20882.
  17. Mirambo M.M., Majigo M., Aboud S. et al. Serological makers of rubella infection in Africa in the pre vaccination era: a systematic review. BMC Res. Notes. 2015, 8: 716. http://www. ncbi.nlm.nih.gov/pubmed/ doi: 10.1186/s 13104-015-1711 -x.
  18. Rasmussen S.A. Jamieson D.J. What obstetric health care providers need to know about measles and pregnancy. Obstet Gynecol. 2015 (Jul); 126 (1): 163-170. doi: 10.1097/ AOG.0000000000000903.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Nozdracheva A.V., Semenenko T.A., Mardanly S.G., Rotanov S.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies